Asia Pacific Typhoid Fever Vaccines Market

BMI RD

Asia Pacific Typhoid Fever Vaccines  Market to 2027 - Country Analysis and Forecast by Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine and Others) and  Route of administration (Oral and Injectable)

Pages: 168    

Market Introduction

Typhoid is an infectious disease caused by Salmonella Typhi, through ingestion of contaminated food and water. This intense illness is identified by prolonged fever, headache and nausea, loss of appetite and constipation or sometimes diarrhea. Increasing threats of typhoid and growing threats of drug resistance has helped typhoid vaccines to boost its market especially among rural and hard-to-reach communities where progress in medical services, infrastructure and development may be slow.

Market Overview and Dynamics

The Asia Pacific typhoid fever vaccines  market is expected to reach US$ US$  135.79 million in 2027 from US$  64.75 million in 2019. The market is estimated to grow with a CAGR of 10.0% from 2020-2027.  Factors such as increasing prevalence of typhoid fever in Asia and typhoid immunizations programs are the key factors contributing to the growth of the market. On the other hand, the market is likely to have negative impact due to risk of associated with typhoid fever vaccines.

Key Market Segments

On the basis of vaccine type, the typhoid fever vaccines market has been segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR in the market during the forecast period. Typhoid fever vaccines market based on route of administration is segmented into oral and injectable. The injectable segment held the largest share of the market in 2019, whereas the oral segment is anticipated to register the highest CAGR in the market during the forecast period

Major Sources and Companies Listed

Some of the major secondary sources for Asia Pacific typhoid fever vaccines  market included in the report are, All India Institute of Medical Sciences, Navi Mumbai Municipal Corporation, International Trade Administration, World Health Organization, China International Publishing Group (CIPG) and others.

Reasons to buy the report

• To understand the Asia Pacific typhoid fever vaccines  market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific typhoid fever vaccines  market
• Efficiently plan M&A and partnership deals in Asia Pacific typhoid fever vaccines  market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific typhoid fever vaccines  market
• Obtain market revenue forecast for market by various segments from 2019-2027 in Asia Pacific.

Asia Pacific Typhoid Fever Vaccines Market –

By Vaccine Type

• Live Attenuated Vaccine
• Capsular Polysaccharide Vaccines
• Conjugate Vaccine
• Others

By Route of Administration

• Oral
• Injectable

By Country

• China
• India
• Japan
• South Korea
• Australia
• Rest of Asia Pacific  

Company Profiles

• GlaxoSmithKline plc
• Shanghai institute of biological products co., Ltd
• PT Bio Farma
• BIO-MED
• BHARAT BIOTECH

Asia Pacific Typhoid Fever Vaccines Market Strategic Insights

Asia Pacific Typhoid Fever Vaccines Market Segmentation Analysis

Asia Pacific Typhoid Fever Vaccines Market Report Highlights

Asia Pacific Typhoid Fever Vaccines Report Scope

Asia Pacific Typhoid Fever Vaccines Market Country and Regional Insights